section name header

Pronunciation

FEN-ter-meen

Classifications

Therapeutic Classification: weight control agents

Pharmacologic Classification: appetite suppressants

Indications

REMS


Action

  • Decreases hunger by altering the chemical control of nerve impulse transmission in the appetite control center of the hypothalamus.
Therapeutic effects:
  • Appetite suppression with resultant weight loss.

Pharmacokinetics

Absorption: Unknown.

Distribution: Unknown.

Metabolism/Excretion: Metabolized by the liver.

Half-Life: 19–24 hr.

Time/Action Profile

(appetite suppression)

ROUTEONSETPEAKDURATION
POunknownunknown4 hr

For 8-mg tablets, increase to 12–14 hr for 30-mg capsules or 37.5-mg tablets.

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: hypertension, palpitations, tachycardia, VALVULAR ABNORMALITIES

EENT: blurred vision

GI: constipation, diarrhea, dry mouth, nausea, unpleasant taste, vomiting

GU: changes in libido, erectile dysfunction

Neuro: CNS stimulation, confusion, dizziness, dysphoria, euphoria, headache, insomnia, mental depression, restlessness

Resp: PULMONARY HYPERTENSION

Interactions

Drug-drug:

Route/Dosage

Availability

(Generic available)

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Adipex-P, Lomaira

Contr. Subst. Schedule

Schedule IV (C-IV)

Code

NDC Code